COF-based nanoreactors for click-activated prodrug delivery and precise anti-vascular therapy
- 2 September 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (79) , 11107-11110
Abstract
Herein, we report a new click-activated prodrug, CA4V, and a bioorthogonal nanoreactor, CA4V/ZIF-90@TzCOF@Apt, which consists of a ZIF-90 core, tetrazine-based covalent organic framework (COF) shells and an aptamer polymer coating. When targeting a tumor, the acid-causing collapse of ZIF-90 initiates a nanoconfined bioorthogonal reaction in defined COF cages, which boosts the click efficiency of CA4V activation and therapeutic effects in vivo.Keywords
Funding Information
- National Natural Science Foundation of China (21974039)
- China Postdoctoral Science Foundation (2020TQ0092, 2020M682537, 2022M711108, BX20220309)
- Department of Science and Technology of Hunan Province (2020RC2019)
- National Key Research and Development Program of China (2019YFA0210103)
This publication has 30 references indexed in Scilit:
- Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug MonotherapyACS Medicinal Chemistry Letters, 2017
- Vinyl Ether/Tetrazine Pair for the Traceless Release of Alcohols in CellsAngewandte Chemie International Edition, 2016
- Tetrazine‐Responsive Self‐immolative LinkersChemBioChem, 2016
- A Bioorthogonal Near-Infrared Fluorogenic Probe for mRNA DetectionJournal of the American Chemical Society, 2016
- In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue SarcomaACS Central Science, 2016
- Development and application of bond cleavage reactions in bioorthogonal chemistryNature Chemical Biology, 2016
- Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell DeathCell, 2015
- Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central RegionsSmall, 2015
- Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine LigationAngewandte Chemie International Edition, 2013
- Novel Combretastatin Analogues Effective against Murine Solid Tumors: Design and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1998